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Introduction
Prostate cancer is the second major cause of cancer-relat-
ed deaths and the most common cancer diagnosed in men 
in the United States and Europe. Prostate cancer incidence 
increases with age (1,2). It is initially androgen-dependent 
(AD) but it will progress to become a more invasive and 
androgen-independent form with resistance to treatment 
(3). The apoptotic process is an important target in treat-
ment of cancer. Apoptosis or programmed cell death is 
characterized by process of autonomous cellular elimina-
tion which avoids eliciting inﬂammation (4).
Apoptosis can be triggered by 2 main pathways; one is 
the extrinsic death-receptor pathway and the other is the 
intrinsic mitochondrial pathway (5). The main treatment 
for most cancers is chemotherapy but it has side effects 
such as decreasing the number of peripheral blood cells or 
toxic adverse effects (6). Thus, in recent years the medici-
nal plant compounds are used to treat cancer. Flavonoids 
and flavonoid-rich food sources have been reported to be 
used for the treatment of several diseases with their pow-
erful antioxidant activities (7).
Hesperetin (3’,5,7-trihydroxy-4’-methoxyflavanone), a 
member of the flavonoids, is found in fruits such as or-
anges and red fruits (8). Many reports have shown that 
flavonoids have various anticancer effects such as kinase 
activity, the inhibition of cell proliferation, and the induc-
tion of apoptosis on cancer cells (9). Hesperetin and its 
metabolites have several biological activities such as an-
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Implication for health policy/practice/research/medical education:
Hesperetin has anti-cancer properties against different cell lines and this effect seems to be through the inhibition of cell proliferation 
with the induction of cell cycle arrest at the G1 phase. These results can be a step toward targeted combination or alternative 
chemotherapy in the prostate cancer.
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Introduction: Prostate cancer is the second leading cause of cancer-related deaths and the most 
common cancer diagnosed in men in the United States and Europe. Hesperetin, a member of the 
flavonoids with antioxidant property, is found in fruits such as oranges and red fruits. This study 
was undertaken to evaluate the effects of hesperetin on apoptosis induction and inhibition of cell 
proliferation in the prostate cancer PC3 cells.
Methods: PC3 cell line was cultured in standard condition. The cells were exposed to different 
concentrations of hesperetin (0-1000 μM) for 48 hours. Cell viability was measured by MTT assay. 
Apoptosis induction was assessed by Annexin V-FITC by flow cytometry analysis.
Results: The PC3 cells exposed to hesperetin (0-1000 μM) exhibited an IC50 (inhibitory 
concentration of 50%) about 450 μM. At different concentrations of hesperetin (400, 450 and 500 
µm), the apoptosis increased slightly (not significant) in treated PC3 cells compared to the control 
group (5.4%, 7.8% and 9.1% respectively vs. 4.2%).
Conclusion: These results clearly show that hesperetin can lead to inhibition of PC3 cells 
proliferation. 
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tioxidant, anti-inflammatory, and lipid lowering effects 
(10). Hesperetin has also been shown to act as a neuro-
protective compound (11) and some studies are indicative 
of hesperetin neuroprotective properties against apoptosis 
(12,13). Therefore, considering the antioxidant properties 
of hesperetin, the aim of this study was to examine the ef-
fects of hesperetin on apoptosis induction and inhibition 
of cell proliferation in the prostate cancer PC3 cells.
Materials and Methods
Reagents
The human PC3 prostate cancer cells were purchased 
from Pasteur Institute of Iran (Tehran, Iran). RPMI1640 
medium, PEN/STREP, dimethyl sulfoxid (DMSO), trypan 
blue, and hesperetin were obtained from Sigma (St. Lou-
is, MO). Fetus bovine serum (FBS) was purchased from 
GIBCO (USA) institute. MTT were acquired from Merck 
(Darmstadt, Germany). 
Cell culture and cell count
The human PC-3 cells were maintained in RPMI 1640 
supplemented with 10% fetal bovine serum (FBS), 100 
U/mL penicillin, 0.1 mg/mL streptomycin (PS). The cells 
were maintained at 37°C in a humidified incubator with 
5% carbon dioxide. Total and viable cell counts (survival 
rate) were determined by standard hemocytometer proce-
dures with the trypan blue exclusion test. Live viable cells 
were seen as colorless (impermeable to the dye due to in-
tact membrane) and dead cells were seen as blue (perme-
able to dye due to disruption of cell membrane).
Determination of cell viability (MTT assay) 
The cytotoxic effects of the hesperetin on the PC3 cells 
were determined by the MTT assay (14). The principle 
behind this technique depends on the capacity of living 
cells to reduce tetrazolium salt [3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide] to a formazan 
crystal in their metabolizing mitochondria. Briefly, PC3 
cells were seeded at an amount of 5 × 103 cells per well 
in 96-well plates and allowed to grow overnight. The cells 
were treated with different concentrations (0-1000 µM) of 
hesperetin (solution in DMSO with 0.1% final concentra-
tion). After incubation for 48 hours, supernatant was dis-
carded and was added 100 µL colorless RPMI. Then, add-
ing 10 µL MTT (5 mg/mL in phosphate buffered saline) to 
each well and incubated for 4 hours. After the removal of 
the medium, 150 µL DMSO was added to each well and 
shaken gently and carefully. The absorbance was read at 
a wavelength of 490-620 nm using an ELISA microplate 
reader (State Fax® 2100, Awareness, USA).
Analysis of apoptosis and necrosis
The analysis of apoptosis was conducted by flow cytom-
etry. Apoptosis was measured by kits specifically (BD 
Biosciences) according to the manufacturer’s instructions. 
Briefly, PC3 cells were cultured in 6-well plates and al-
lowed to attach to plate overnight. The cells were treated 
with 450 μM of hesperetin for 48 hours and they were har-
vested by trypsinization and, after washing with cold PBS, 
were diluted with 500 µL of binding buffer, and incubated 
in 10 µL of Annexin-binding buffer with 2 µL of Annexin 
V-FITC for 20 minutes in the dark. Then, the cells were 
acquired and analyzed by flow cytometry (15).
Statistical analysis
The data were expressed as mean ± S.D. They were ana-
lyzed by SPSS software (version 20) and Graph Pad Prism 
(version 5.01, USA). Nonparametric data were analyzed 
with Kruskal-Wallis test. A P ≤ 0.05 was considered sig-
nificant. All experiments were repeated at least 3 times.
Results
Figure 1 shows that hesperetin has decreased significantly 
cell proliferation in a dose-dependent manner (P < 0.05) 
after 48 hours. The cells that exposed to hesperetin (0-
1000 μM) exhibited an IC50 (inhibitory concentration of 
50%) about 450 μM. In this concentration, hesperetin 
eliminated 50% of the cells.
Effect of hesperetin on apoptosis in PC3 cells
Figures 2 and 3 show flow cytometric analysis using An-
nexin V staining for apoptosis in PC3 cells. Apoptosis in 
PC3 cells was slightly induced (not significantly) 5.4%, 
7.8% and 9.1% at 400, 450, and 500 µM of hesperetin, re-
spectively.
Discussion
Chemotherapy is considered as the main treatment for 
most types of cancers but because of side effects, major ef-
forts have been made to recognize natural compound that 
can prevent the development of cancers. Many natural 
compounds have been found to induce apoptosis in vari-
ous cancer cells and there are obvious evidences indicating 
that these compounds are potent inhibitors of cancer cell 
Figure 1. Inhibition of cell proliferation by hesperetin for 48 h. 
The cells were cultured at the density of 5 × 103 cells per well in 
96-well plates and were allowed to grow overnight. The cells were 
treated with different concentrations (0-1000 µM) of hesperetin 
(solution in DMSO 0.1%) after incubation for 48 hours.
Effects of hesperetin on apoptosis 
Journal of HerbMed Pharmacology, Volume 4, Number 4, October 2015http://www.herbmedpharmacol.com 123
proliferation (16,17). This beneficial effect has often been 
attributed to the high content of naturally-occurring an-
tioxidants, such as vitamins and flavonoids. In particular, 
studies have indicated a specific link between citrus intake 
and the reduced risk of diseases such as cancer (18,19).
In the present study, we analyzed the effects of hesperetin 
(a flavonoid) on PC3 cells. The effects of this antioxidant 
were assessed on growth and proliferation of PC3 cells in 
vitro using an MTT assay or cytotoxicity assay test (Figure 
1). Hesperetin in 450 μM led to the reduction of cell vi-
ability as reported by other investigators (20,21). Our re-
sults of flow cytometry indicate that apoptosis increased 
slightly (not significantly) in hesperetin-treated PC3 cells 
compared to the control group (Figures 2 and 3). Previous 
studies have also shown that hesperetin treatment leads to 
the inhibition of cell proliferation with the induction of 
cell cycle arrest at the G1 phase (22). Nevertheless, Palit 
et al (23) showed that hesperetin would induce apoptosis 
in breast carcinoma by triggering aggregation of reactive 
oxygen species (ROS) and activation of ASK1/JNK sig-
naling pathway (23) which runs counter to our findings. 
On the other hand, some studies have demonstrated that 
hesperetin has antioxidant, anti-proliferation, and apop-
tosis effects (24). Also, it was found that hesperetin at 100 
nM was effective in preventing neuronal apoptosis via a 
mechanism involving the activation/phosphorylation of 
both ERK1/2 and Akt/PKB signaling pathways (11). Choi 
et al showed that hesperetin and epigallocatechin gallate 
exerted antiapoptosis effects in endothelial cells exposed 
to oxidized LDL. They showed that hesperetin was medi-
ated by interrupting both JNK and p38 MAPK-responsive 
death pathways (25). Also, in another study it was found 
Figure 2. Effect of hesperetin on apoptosis in PC3 cells. The 
cells were cultured for 24 hours. Then, the cells were treated with 
different concentrations of hesperetin (0, 400, 450, 500 µM) for 
48 hours. The appearance of apoptosis cells was detected by 
flow cytometry using Annexin V-FITC staining. A; Control without 
treatment, B, C and D the cells were treated with 400, 450, and 
500 μM of hesperetin, respectively.
Figure 3. The effect of different concentrations of hesperetin 
on PC3 cells apoptosis after 48 hours incubation compared to 
control group. No significant change (P > 0.05) was observed in 
apoptosis and necrosis between hesperetin-treated PC3 cells 
and control group cells different concentrations of hesperetin.
that protective effects of hesperetin and naringenin against 
apoptosis in ischemia/reperfusion induced retinal injury 
in rats. As a result hesperetin and naringenin can prevent 
harmful effects induced by I/R injury in the rat retina by 
inhibiting apoptosis of retinal cells, which proposes that 
those flavanones have a therapeutic potential for the pro-
tection of ocular ischemic diseases (10). Therefore, in this 
study the prevention of PC3 apoptosis probably resulted 
in the changes of cellular signaling proteins.
In this study, we did not evaluate the effect of hesperetin 
on cellular signaling proteins such as the nuclear translo-
cation level of p65, ERK1/2, Akt/PKB, and regulatory ef-
fectors such as Bcl2 levels, and Bax levels. These factors 
can influence cell apoptosis and survival. Therefore, we 
suggest that future studies focus on the effects of EA on 
other cell signaling and effector proteins.
In conclusion, our data confirmed that hesperetin led to 
the reduction of PC3 cells without considerable increasing 
apoptosis considerably. Therefore, the study of the mecha-
nism of apoptosis induction could be a step of progress 
toward target therapy which might be considered in the 
future studies.
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